Philip Morris
Measurement of Asbestos Retention in the Human Respiratory System Related to Health Effects
Fields
- Author
- Bignon, J.
- Gaudichet, A.
- Sebastien, P.
- Gaudichet, A.
- Type
- SCRT, REPORT, SCIENTIFIC
- ABST, ABSTRACT
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- DRAW, DRAWING
- PHOT, PHOTOGRAPH
- ABST, ABSTRACT
- Area
- SOLANA,RICHARD/CENTRAL FILES
- Litigation
- Fali/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R545
- Named Organization
- Ministere De La Qualite De La Vie
- Natl Bureau of Standards
- Univ College of Cardiff
- Workshop on Asbestos
- Icrp Task Group
- Ilo Uc Intl
- Institut Natl De La Sante Et De La Reche
- Laboratoire De Biophysique Medicale
- Laboratoire Des Particules Inhalees
- Natl Bureau of Standards
- Author (Organization)
- Centre Hospitalier Intercommunal
- Direction Departmentale De Laction Sanit
- Institut De Recherche Sur Lenvironnement
- Laboratoire Des Particules Inhalees
- Universite Paris Val De Marne
- Direction Departmentale De Laction Sanit
- Named Person
- Berry, J.P.
- Bignon, J.
- Evans
- Fisher, R.
- Galle, P.
- Morgan, A.
- Pooley, F.D.
- Schneiderman, M.
- Sebastien, P.
- Stanton
- Suzuki
- Timbrell
- Wagner
- Wright, G.
- Bignon, J.
- Master ID
- 2063104795/5283
Related Documents:- 2063104795-5283 Proceedings of Workshop on Asbestos: Definitions and Measurement Methods Proceedings of A Workshop on Asbestos Held at the National Bureau of Standards, Gaithersburg, Maryland, 770718 - 770720
- 2063104803-4820 History of Asbestos - Related Mineralogical Terminology
- 2063104821-4835 Fibrous and Asbestiform Minerals
- 2063104836-4849 the Crystal Structures of Amphibole and Serpentine Minerals
- 2063104850-4864 the 'asbestos' Minerals: Definitions, Description, Modes of Formation, Physical and Chemical Properties, and Health Risk to the Mining Community
- 2063104865-4870 General Discussion of Mineralogical Aspects
- 2063104871-4893 Epidemiological Evidence on Asbestos
- 2063104919-4930 Epidemiologic Evidence of the Effect of Type of Asbestos and Fiber Dimensions on the Production of Disease in Man
- 2063104931-4940 Pathophysiology in Relation to the Chemical and Physical Properties of Fibers
- 2063104941-4949 the Carcinogenicity of Fibrous Minerals
- 2063104950-4958 Niehs Oral Asbestos Studies
- 2063104959-4973 Epa Study of Biological Effects of Asbestos - Like Mineral Fibers
- 2063104974-4985 A Study of Airborne Asbestos Fibers in Connecticut
- 2063104986-4995 General Discussion of Relationship Between Chemical and Physical Properties and Health Effects
- 2063104996-5015 Identification of Selected Silicate Minerals and Their Asbestiform Varieties
- 2063105016-5029 An Overview of Electron Microscopy Methods
- 2063105030-5043 Identification of Asbestos by Polarized Light Microscopy
- 2063105044-5064 Mineral Fiber Identification Using the Analytical Transmission Electron Microscope
- 2063105065-5074 Transmission Electron Microscopical Methods for the Determination of Asbestos
- 2063105075-5088 Statistics and the Significance of Asbestos Fiber Analyses
- 2063105089-5106 Selection and Characterization of Fibrous and Nonfibrous Amphiboles for Analytical Methods Development
- 2063105107-5117 Asbestiform Minerals in Industrial Talcs: Commercial Definitions Versus Industrial Hygiene Reality
- 2063105118-5131 the Detection and Identification of Asbestos and Asbestiform Minerals in Talc
- 2063105132-5146 Misidentification of Asbestos in Talc
- 2063105147-5155 Ambient Air Monitoring for Chrysotile in the United States
- 2063105156-5167 Environmental Protection Agency Interim Method for Determining Asbestos in Water
- 2063105168-5171 Inter-Laboratory Measurements of Amphibole and Chrysotile Fiber Concentration in Water
- 2063105172-5177 the Standard for Occupational Exposure to Asbestos Being Considered by Astm Committee E-34
- 2063105178-5193 Identification and Counting of Mineral Fragments
- 2063105194-5202 Practical Aspects of Talc and Asbestos
- 2063105203-5210 General Discussion of Analytical Methods
- 2063105211 Introduction
- 2063105212-5219 the Mining Enforcement and Safety Administration - Regulations and Methods
- 2063105220-5229 Occupational Safety and Health Administration Methods
- 2063105230-5236 FDA Projects and Methods
- 2063105237-5238 Cosmetic Talc Powder
- 2063105239-5248 Cpsc Regulation of Non-Occupational Exposure to Asbestos in Consumer Products
- 2063105249-5255 Impact of Asbestos Regulations on the Mining Industry
- 2063105256-5265 General Discussion of Regulatory Aspects
- Date Loaded
- 20 Sep 1999
- UCSF Legacy ID
- mbp52d00
Document Images
CS
National Bureau of Standards Special Publication 5D6. Proceedings of the Workshop on
Asbestos: Definitions and Measurement Methods held at NBS, Gaithersburg, MD, July 18-20,
1977. (Issued November 1978)
MEASUREMENT OF ASBESTOS RETENTION IN THE HUMAN RESPIRATORY SYSTEM RELATED TO HEALTH EFFECTS
J. Bignon, P. Sebastien, and A. Gaudichet
Universit Paris-Val de Marne - Institut de Recherche sur 1'Environnement
Centre Hospitalier Intercommunal
94010 Creteil, France
and
Laboratoire des Particules Inhal4es
Direction Departmentale de l'Action Sanitaire et Sociale
75013 Paris, France
Abstract
The retention pattern of asbestos fibers in the human respiratory
system is related to four mechanisms: penetration into the respiratory
tract deposition on the surface of respiratory epithelium, clearance,
and intra-tissular translocation of asbestos fibers. Knowledge of such
retention pattern for people exposed to asbestos dusts could provide
useful information concerning the role of these mechanisms and the
pathogenicity of fibers. So, asbestos fibers content has been assessed
by light and electron microscopy in different samples from the
respiratory tract: sputum, broncho-alveolar washing fluid, lung
parenchyma, parietal pleural, and mediastinat lymph nodes from people
diversely exposed to asbestos dusts and affected by various asbestos-
related diseases. In each sample, asbestos fibers, identified as
chrysotile or amphibole, have been counted and measured (length and
diameter).
It has been shown that asbestos fibers found in sputum and in
broncho-alveolar washing fluid by light and electron microscopy were
reliable for the assessment of inhaled asbestos fibers in the workplace
or in the environment.
Analytical data concerning asbestos burden in respiratory tissues
can be summarized as follows:
- despite the fact that most of the consumed asbestos is of
chrysotile type, amphibole was more frequently found in lung parenchyma
than chrysotile, in most cases;
- most of the fibers retained in lung tissues were less than 0.20 pm
in diameter and shorter than 5 pm. The intra-alveolar fibers were
shorter (3.3 pm) than fibers found in lung parenchyma (4.9 pm). Fibers
encountered in mediastinal lymph nodes were shorter (2.5 pm) and of
amphibole type, whereas fibers encountered In parietal pleura were the
shortest (2.3 Nm), and thinnest (0.06 pm in diameter) and mostly of
chrysotile type.
The signification of these data concerning the topographic
variation in the fiber type and size are discussed in relationship with
adverse health effects, particularly carcinogenesis.
Key Words: Asbestos; carcinogenesis; fibers; pathogenicity; respiratory
tract.
Preceding page blank
95

Introduction
The factors relevant to the assessment of public health risks of exposure to asbestos
have been recently reviewed in two documents [1,2]1. It is now well documented that
exposure to asbestos dust can lead to the development of lung fibrosis, bronchogenic
carcinoma, pleural plaques, pleurisy, mesothelioma, gastro-intestinal tumors, and perhaps
other unexpected diseases. The most critical point today is the establishment of dose-
response relationship. Regarding cancer, adequate data to establish a threshold limit are
not yet available. "The existence of a theoretical no-effect level may even be doubted;
however, there may exist ; a rac4cT no-e ect level-6eTow wTicF any excess incidence
cannot be adequately establ ished .
As far as asbestos is concerned, because of the various possibilities of exposure, it
is difficult to define retrospectively sharp conditions of exposure. So, the exposure-
effect relationships are not very reliable and greater reliance should be put upon
biological monitoring. Asbestos metrology in human samples could provide information
about the most important questions arising for the assessment of dose-effect relationships
and for the subsequent definition of prevention practices:
A. Is there any relationship between one or several body-burden parameters at
autopsy and the cause of death, sex, age, and possibilities of exposure? The problem is
that the latency period of asbestos-induced diseases can be very long (up to 30 or 40
years). As the accumulation of fibers in man occurs in a dynamic way (related to
inhalation and clearance mechanisms), only the residue-burden can be investigated at
autopsy. Research is needed to establish eventual relationships between autopsy residue-
burden and burden at the time of disease onset.
B. What is the most suitable external indicator of body-burden during life? Such a
contamination indicator, if it exists and if available for monitoring, could be very
helpful for the detection or the survey of exposed people. If relationships could be
established with related diseases or with any biological test, this kind of survey should
be specifically relevant to biological monitoring.
C. What is the biological significance of physical and chemical properties of fibers
(length, diameter, elemental composition, associated pollutants...) regarding the
induction of diseases (particularly tumors)?
Recent experimental data using intrapleural implantation [3] or intraperitoneal
injection [4] of fibers of different sizes indicated clearly that the size parameters are
the most important for inducing cancer and that the most carcinogenic fibers, whatever the
chemical composition, are those with diameters of less than 0.5 or 0.25 pm, and length
more than 5 or 8 pm [5]. How can information provided by asbestos measurements in human
respiratory tissues be correlated with these recent findings?
0. These studies on body-burden correlated to environmental monitoring could lead to
more appropriate standards or quality guides for the future, in relation to the prevention
of asbestos-related cancers.
General Considerations Related to Asbestos Retention
A. What Could Be the Definition of Body-Burden for Asbestos.
The actual amount of pollutants in humans at any time is called retention. The
retention of particles In humans occurs in a dynamic way and reaches an equilibrium level
depending on the relative rate constants of deposition and clearance processes. The model
of lung retention, based on the ICRP Task Group report [6], is suitable for describing the
general scheme of deposition, clearance, penetration, and translocation of fibers in
humans, as shown in figure 1. So far, the penetration and retention of asbestos fibers
through the gastro-intestinal tract have not been intensively investigated [7].
1Figures in brackets indicate the literature references at the end of this paper.
96

CS
Dust in inspired and expred ai-
Nasopharynx cofnpartment
1'
Blood
Tracheo - bironchial
compartment
Alveolar compartment ~'
~. Parenchymal , tissue
Sputum
Gastro-
intestinal
tract
~
~
I
Pulmonary lymph ~ ~
vessels and node '~s
Pleural tissue
4
:
Feces
Figure 1. General scheme for deposition, clearance, translocation and retention of
fibers, derived from the ICRP lung model [6]. (Heavy arrows : deposition;
light dotted arrows : clearance pathway; light arrows : translocation
pathways.) '
As asbestos measurement in tissues requires a destructive process, the retention of
asbestos fibers cannot be controlled continuously. Measurement of asbestos in organs will
provide information on asbestos retention at a very definite time: time of death for
autopsic material, or time of surgical intervention for biopsic samples. So far, few
attempts have been made for monitoring asbestos retention in alive people either by means
of external magnetic procedure involving no sampling [8], or by means of relating body-
burden to the amount of asbestos in sputum [9,10], in gastric juice [11], and in feces
[12].
B. Deposition.
Distinction has to be made between the two pathways for human exposure to asbestos:
the pulmonary tract (PT) and the gastrointestinal tract (GIT).
Timbrell has reviewed the mechanisms by which particles deposit in the respiratory
system and has addressed specifically to the problem of fibers deposition [13]. He
identified settling, inertial impaction and Brownian diffusion as deposition mechanisms
which operate for both compact particles and fibers. In addition, he listed a fourth
mechanism, direct interception, which is of little significance for compact particles but
which may be of marked importance for fibers. In this view, a model for deposition of
fibers in the human respiratory system has been described [14]. The effectiveness of
these deposition mechanisms depends on the anatomy of the respiratory tract, the effective
aerodynamic diameter of the particles (size, shape, density), and the breathing pattern.
Asbestos fibers can also deposit in the gastrointestinal tract (GIT) either directly
(because of the presence of asbestos in water, beverages and food) or indirectly (fibers
coming from the respiratory airways and being swallowed). So far, there is little or no
direct information regarding the way of fiber deposition at the surface of the human GIT.
97
2063104896

It, is obvious that accurate quantitative information on the deposition of asbestos
fibers in humans is difficult to be obtained because of clearance and translocation
mechanisms occurring simultaneously during lifetime. What we measure in the human body
results from all these associated mechanisms!
C. Clearance.
Fibers which are deposited on the muco-ciliated blanket of the trachea and bronchi
move toward the pharynx. The clearance of inhaled particles by this mechanism is believed
to be more than 98 percent effective for most deposited particles [6]. However, the
direct toxic effect of asbestos on the ciliated cells, as shwon recently [15], must impair
the effectiveness of this clearance mechanism.
The fibers deposited at the surface of the alveoli are either taken by alveolar
macrophages or entrapped within the alveolar lining film. From there, some of them are
cleared towards the ciliated airways while others should penetrate the alveolar membrane.
The clearance is different according to the type of asbestos; for chrysotile, the
clearance is important, since Wagner et al. [16], Morgan et al. [17] found that a large
percentage of chrysotile asbestos entering the lungs of rats may be removed from the lungs
within 58 days; but we do not know the mechanisms involved. However, most of the cleared
fibers must reach the GIT as demonstrated by the study of Evans et al. [18] using inhaled
neutron activated asbestos; up to 73 percent of this asbestos was found in the feces
within 30 days.
Measurements related to clearance in human have been carried out in several kinds of
samples: sputum [10,19,20], gastric juice [11], and feces [12]. Generally, the finding
of asbestos in such samples was related to past exposure, pulmonary burden or pathological
features. The feasibility of using such samples as indicators of body-burden will be
discussed later.
D. Penetration and Translocation of Asbestos Fibers in the Human Body.
Measurements in tissues using the transmission electron microscope (TEM) have
revealed the presence of numerous fibers and fibrils far more than was ever imagined when
the fiber population was evaluated by light microscopy alone. These findings, occurring
even in case of moderate exposure and long elapsed time from last exposure, suggest a very
high penetration and retention rate for TEM size fibers. In humans, asbestos fibers have
been found by TEM in lung parenchyma by many authors [21,22,23, 24,25,26,27] and also in
bronchial tissue, lymph nodes [28], parietal pleura [25,26], pleural fluid (29,30],
peritoneum [31], liver [24], stomach [32,33], bowel walls [34], and colon [353. These
findings suggest the penetration of asbestos in the human tissues and their migration
throughout the whole body.
Experimentally, penetration of fibers across the alveolar epithelium has been
described in TEM by Suzuki (36]. The extreme tendency of asbestos fibers to migrate has
also been demonstrated experimentally after subcutaneous injection [37], intrapleural or
intraperitoneal inoculation [38,39,40], or after ingestion [41].
However, the penetration of ingested fibers through the wall of the gastrointestinal
tract is still in discussion. This point is mostly relevant to asbestos-related extra-
thoracic cancers, such as peritoneal mesothelioma, ovarian carcinoma, kidney carcinoma,
etc. Some authors pointed out that there was no penetration [42]. However, an experiment
In progress in our laboratories has shown that ingested chrysotile and crocidolite fibers
did cross the intestinal barrier in the rat, being recovered in the lymph of the thoracic
duct [43].
98

Analytical Data Related to Asbestos Body-Burden in Humans
A. Sam les Studied as Indicators of Asbestos Body-Burden.
' So far, most of the samples studied in this laboratory for estimating asbestos body-
burden in humans were collected from the respiratory tract. We will only focus on data
obtained from measurements in 3 kinds of samples: lung washing fluid (LWF) obtained by
broncho-alveolar lavage (BAL), sputum collected on alive people, and respiratory tissues
(lung parenchyma (LP), parietal pleura (PP), and mediastinal lymph nodes (LN) sampled at
autopsy).
According to the model shown in figure 1, it has been assumed that asbestos fibers
found in LWF were related, on one hand to the intra-alveolarly deposited fraction of
inhaled fibers, and on the other hand to the fraction cleared from the deep lung whereas
those found in sputum must be related to the fibers cleared from the deep lung and from
the tracheo-bronchial compartment [20]. The fibers detected by destroying lung parenchyma
correspond to intra-alveolarly deposited fibers and intra-tissularly retained fibers at
the time of autopsy.
The point is to know if LWF and sputum can be used as external indicators of asbestos
body-burden. In this view, a systematic comparative study of fibers encountered in LWF,
in sputum and in lung tissue has been carried out and is still in progress.
B. Analytical Procedures.
For this study, the patients were classified according to their past asbestos
exposure. A meticulous history was obtained by questioning each patient in detail about
their successive occupations since leaving school. When a history of asbestos exposure
was found, the duration of this exposure and the lapse-time since last exposure was
recorded (expressed in years). Thus, the degree of exposure was estimated on one hand in
terms of its duration and on the other hand according to the type of work done by the
patients.
All the biological samples were collected within 10 percent formalin. For autopsic
lungs, the formalin was injected intratracheally. Pieces of tissue samples were cut and
their volume measured. Typically, 1 cc of tissue was prepared for analysis.
Each sample to be analyzed was put in a glass vessel containing sodium hypochlorite.
This digestive procedure was performed at room temperature during one or two hours. Then,
the mixture was directly filtered through a 0.4 pm pore size Nuclepore membrane filter
previously coated with a carbon layer.
At this stage the filter was scanned under the light microscope looking for
ferruginous bodies.
For TEM study, a second carbon layer was deposited upon the filter and the particles,
entrapped in a double carbon-film, were transferred to TEM grids. The preparations were
scanned at X 30,000 direct magnification, looking for fibers. Each fiber encountered was
identified on the basis of its morphological features and its electron diffraction pattern
and was called chrysotile, amphiboles, or non-asbestos fiber. The length and diameter of
each asbestos fiber was measured using a calibrated mark on the viewing screen. For each
grid square scanned, the data (number, mineralogical type, and size of fibers) were
recorded directly on a computer. Several grid squares were scanned until the variation
around the mean calculated for numerical concentrations was less than 30 percent.
Concentrations of fibers were expressed in terms of number per sputum, number per
total lung washing fluid recovered, and number per cc of tissue.
Identification of associated non-fibrous particles has been assessed by means of
electron microprobe analysis [44], but quantitative information concerning numerical or
mass concentration of such particles has not been obtained.
99
2063104898

An intercomparison study between two laboratories (The University College of
Cardiff - F. D. Pooley and Laboratoire des Particules Inhalees, Paris - P. Sebastien) has
yielded very similar results concerning the assessment of asbestos fibers in tissues,
using the procedure previously described [45].
C. Lung Washing Flui'd (LWF).
The possibility of assessing the asbestos endo-alveolar content by means of broncho-
alveolar lavage is now under investigation in diversely exposed people. Such a technique
has been used by different workers in order to collect free cells and proteins from the
human lung [46,47] and it has been shown in the baboon that pulmonary washing was an
efficient procedure for the recovery of particles deposited in the alveolar compartment of
the lung [48].
1. Material and Method
Up to date, this type of investigative procedure has been used in 26 cases (Table 1).
The cases studied were divided in 4 groups:
Table 1. Groups of 26 patients investigated by broncho-alveolar lavage.
Nb Cases Asb. Exposure Diseases
Definite Asb : 9
Group 1 9 Heavy Pl Pl : 5
Br Ca : 1
Definite P1 P1 : 2
Group 2 5 Moderate Silico-Asb : 1
Sm irr op : 1
Chr bronch : 1
Suspected Fibrosis +
Group 3 3 Moderate P1 P1 : 1
P1 P1 : I
Chr bronch : 1
None Lar Ca : 1
tuberculosis : 1
Controls 9 fibrosis : 1
histiocyt, x : 1
Chr bronch : 5
Abbreviations: Nb - number; Asb = asbestosis; P1 P1 - pleural plaques;
Br Ca : bronchogenic carcinoma; Sm irr op small irregular
x-ray opacities; Chr bronch = chronic bronchitis;
Lar Ca = larynx carcinoma.
100

CS
Group 1 included 9 cases with definite heavy asbestos exposure (OH), subdivided into
7 insulation workers, 1 asbestos-cement worker, and 1 asbestos-textile worker. Lung
asbestosis from 0/1 to 2/2 was diagnosed by x-ray according to the IL0 U/C International
classification of radiographs of pneumoconiosis 1971. Asbestosis was associated with
bronchial carcinoma in one case and with pleural plaques in 5 cases (Table 1).
Group 2 included 5 cases with definite moderate asbestos exposure (DM), confirmed by
minutious occupational inquiries. The occupation and associated diseases are indicated in
Tables 1 and 2.
Table 2. Occupations, associated diseases, and mineralogical results in cases of Group 2.
(definite moderate exposure)
Results LWF in Group 2(definite moderate exposure)
Years Years since Nb coated Nb
Cases Occupation occupation asb. exp. Diseases fibers fibers % A
MOU... Boiler Fitter 10 19 P1 P1 10 + 0
GAN... Glass Blower 27 0 P1 P1 0 0 -
MAR... Asbestos 19 11 Silicosis 0 + 50
Plate Cutting ± Asbest.
ESS... Plumber with 18 3 Small Irr 0 0 -
Welding, Brazing Opacities
BOD... Isolation of 3 24 Chronic 0 0 -
Central Heating Bronchitis
Abbreviations: P1 P1 = pleural plaques; Years occupation = years of occupational exposure;
Nb = number; LWF = lung washing fluid; % A= ratio of amphiboles number/
amphiboles number + chrysotile number. (See Table 1 a1so.)
Group 3 included 3 cases with suspected (but not proven) moderate asbestos exposure
(SM) according to the past occupational history of the patients. The occupation and
associated diseases are indicated in Tables I and 3.
Table 3
Results LWF in Group 3 (suspected moderate exposure)
Years Nb coated Nb
Cases Occupation occupation Diseases fibers fibers % A
ABD... Autonabile 10 Chronic 0 + 0
Worker Bronchi ti s
MON... Wood 10 Fibrosis 0 + 0
Worker + P1 P1
DEC... Plumber 25 P1 P1 0 0 -
'Abbreviations: See Table 2.
101
2063104900

CPS
The 9 control cases included patients without specific dust exposure.
The method used for broncho-alveolar lavage (BAL) has been extensively described
elsewhere [49]. It was assumed that the volume of the lung washed by this procedure
corresponded to about one segment. For mineralogical analysis, a 10 mL sample was taken
from the whole lavage before the centrifugation was performed for cells recovery.
2. Results
No asbestos fibers have been detected by LM and TEM in the LWF of the 9 control
cases. Some other no fibrous mineral particles have been encountered in 50 percent of
these cases, identified as chlorite, calcite, quartz, aragonite, phlogopite, magnetite,
and Al metal.
In the group I of heavily exposed patients (Table 4), the mean number of fibers was
12.1x106 per lavage. The mean number of alveolar macrophases (AM) was simultaneously
estimated to be 12.6x108 per lavage. However, there was no correlation between the number
of fibers and the number of AM. Asbestos fibers were mainly of the amphibole type in
insulation or asbestos cement workers. The highest fiber count (50x10 ), only of the
amphibole type, was observed in the patient working in an asbestos-cement plant. By
contrast, in the case of having worked in an asbestos-textile plant, all the fibers were
of the chrysotile type. The percentage of coated fibers was low, less than 1 percent in 7
out of 9 cases. The mean length and diameter were 3.3 and 0.13 pm respectively.
Table 4. Mineralogical studies of lung washing fluid (LWF).
Results LWF in Group 1(definite heavy exposure)
Nb Nb % Mean Mean
Exp. Yrs Yrs since A.M. fibers coated length diam
Cases type exp. last exp. Diseases 106 106 fibers % A µm um
CHA... I 16 2 A 7.6 21 5 100 3.9 0.15
KRE... 1 10 4 A 24.6 5 0.3 100 4.04 0.12
FRA... 1 11 3 A 26.1 6 0.5 100 3.02 0.14
CHE... I 10 11 A + B, CA - 2.4 0.15 100 2.9 0.10
BEN... I 15 4 A - 3.8 0.9 99 3.2 0.15
LAI... I 11 0 A 9.7 11.4 2 90 3.05 0.12
MAA... I 14 3 A+ p1 pl 7.3 7 0.8 100 2.07 0.15
MAR... AC 19 0 A 10.7 50 0.001 100 2.07 0.15
FAL... AT 4 1 A 2.4 3 0.02 0 5.6 -
Average 12.2 3.1 12.6 12.1 1 3.3 0.13
±4 ±3.1 ±8.4 ±14.4 t1.5 ±1 ±0.1
Abbreviations: Exp type = type of exposure; I insulator; AC = asbestos-cement plant
worker; AT a asbestos-textile plant worker; NB A.M. - number of alveolar
macrophages per tavage; Nb fibers = number of asbestos fibers per lavage;
% A see Table 2; diam = diameter.
102

CS
In the group 1, two parameters, duration of exposure in years and lapse-time since the
last exposure, have been assessed and correlated with the fiber count in the LWF. The two
curves show that the number deposited within the alveolus increases with duration of
exposure, whereas this number decreases when the time since the last exposure increases
(figure 2).
t
+ Yrs of exposure
Yrs since the last
exposure
5 10 15 20 Yrs
I I I I
Figure 2. Relationship between fiber count in lung washing fluid and exposure patterns
for cases of group 1(definite heavily exposed people). The fiber count
increases with the duration (years) of exposure; it decreases when the
delay since the last exposure increases.
In this group, the fiber yield obtained by BAL and by collecting one sputum has been
compared (Table 5). The numbers of coated and uncoated fibers were one or two orders of
magnitude higher in LWF than in sputum. Moreover, the fibers were shorter in LWF (mean
length 3 pm) than in sputum (5 Nm). Elsewhere, the proportion of amphibole type fibers
was less in sputum. -
By contrast, in groups 2 and 3, with moderate exposure, the asbestos fiber count in
LWF yielded less significant results (Tables 2 and 3). In some cases, both LM and TEM
analysis were negative. In others, only a few fibers were found, but at a level not
allowing a significant count to be expressed.
103
2063104902

COS
Table S. Comparison of asbestos fibers in sputum and lung washing fluid (LWF)
from cases of Group 1 (9 cases).
Coated
4ibers Uncoated
fibers % amphibole
type fibers Mean
length
um Mean
diameter
um
Sputum
(one sample) 7.102 1.105 65 5 0.16
LWF
(whole lavage) 3.104 5.106 88 3 0.13
In groups 2 and 3, the comparison of asbestos fibers found in sputum and LWF yielded
the following results: in many cases, the numerical concentration was low or null; in
other cases, one or the other sample showed some fibers. The asbestos content either in
sputum or in LWF was similar, within the ranges: 0 to 10 for coated fibers and from not
detectable to 5x10s for TEM size fibers, mostly of chrysotile type.
D. S utum.
It has been demonstrated in this laboratory [9,11] and by others [10] that the amount
of coated fibers or ferruginous bodies (FB) in the sputum was significantly related to the
asbestos exposure and to the amount of FB in lung parenchyma further measured at the
autopsy time [11]. This test is very simple and can be used as a retrospective proof of
asbestos exposure, even in the case of long lapse time after the end of exposure. Another
advantage is that the coating around the fibers is the evidence that the fibers have
stayed in the lung.
The study of sputum can also be good in the case of light exposure if the TEM is
used. As an example, in this laboratory the sputum has been studied from 45 people
working inside buildings insulated with sprayed asbestos containing material. The TEM
examination has shown the presence of TEM size asbestos fibers, only of the chrysotile
type, in 13 cases (29 percent) (Table 6). The influence of duration of exposure on the
presence or not of fibers in sputum has not been demonstrated. Chrysotile fibers were
mostly short microfibrils (0.5 to 2 pm long) and forming clumps, probably entrapped in
mucus (figure 3).
Table 6. Sputum monitoring for asbestos in 45 people working
in asbestos-sprayed buildings.
TEM study
Nb
Percent Mean duration
of exposure (yrs)
Presence of
Fibers
13
29
8.3
Absence of
Fibers
32
71
8.1
~
w
~
g
104 8
w

(CS
Figure 3. Electron micrographs showing chrysotile type fibers isolated from
sputum in people resident inside asbestos sprayed buildings.
E. Respiratory Tissues.
1. Lung Parenchyma
Lung parenchyma samples from 27 autopsic cases diversely exposed to asbestos and with
different malignancies have been studied by TEM. Four blocks of parenchyma were sampled
in different sites of the same lung: central upper lobe, peripheral upper lobe, central
lower lobe, and peripheral lower lobe, as described elsewhere [25]. The geometric mean of
fiber count in the 4 sites has been calculated and then the cases have been classified in
groups according to the asbestos lung burden (Table 7). The proportion of cases having
more than 106 fibers/cc of lung parenchyma was 8 out of 10 for the asbestosis +
respiratory cancer group, 5 out of 11 for the mesothelioma group, 0 out of 2 for the lung
cancer (without associated lung fibrosis) group, and 2 out of 4 for the other malignancies
group.
105
2063104904

e
Table. 7. Asbestos fibers burden in lung parenchyma according to
pathological features.
Pathological Fiber concentration in the lung, Nb cm 3
features ~ <106 106 - 107 >107 Total
Asbestosis t
Respiratory
2
5
3
10
Cancer
Mesothelioma
6
3
2
11
Lung Cancer 2 0 0 2
Others
Malignancies
2
2
0
4
Total 12 10 5 27
The mineralogical type of fibers encountered in lung parenchyma has been assessed by
TEM and the results are expressed in Table 8 by the percentage of amphibole/all asbestos
fibers. The parenchyma retention of amphibole type fibers has been found important in
most cases, the amphibole proportion increasing with fiber concentration in all
pathological groups. Moreover, whatever the fiber concentration in lung parenchyma, the
highest mean proportion of amphibole type fibers was observed in the mesothelioma group.
Table 8. Mineralogical type of fibers in lung parenchyma:
ratio amphiboles/(amphiboles + chrysotile) x 100.
Pathological Fiber concentration in the lung, Nb an 3
features <106 106 - 107 >107 Average
Asbestosis t
Respiratory
38
59
69
58
Cancer
Mesothelioma
53
70
89
64
Lung Cancer 4 4
Others
Maligancies
12
41
26
Several size parameters have been assessed: mean length, mean diameter, and
proportion of fibers longer than 8 pa. The results are shown in Tables 9, 10, and 11
respectively. The main figures are: 1) the size of fibers increases when the
concentration increases; 2) the mean diameter never exceeds 0.16 Nm; 3) the mean
percentage of fibers longer than 8 pm does not exceed 20.8 percent.
106

.T,
Table 9. Size of fibers in lung parenchyma: mean length (um).
Pathological Fiber concentration in the lung, Nb cm 3
features <106 106 - 107 >107 Average
Asbestosis ±
Respiratory
3.7
5.4
5.5
5.1
Cancer
Mesothelioma
4.8
5.7
4.1
4.9
Lung Cancer 1 1
Others
Maiignancies
2.8
2.3
2.6
Table 10. Size of fibers in lung parenchyma: mean diameter (pm).
Pathological Fiber concentration in the lung, Nb cm 3
features <106 106 - 107 >107 Average
Asbestosis t
Respiratory
0.11
0.13
0.16
0.13
Cancer
Mesothelioma
0.09
0.13
0.12
0.11
Lung Cancer 0.05 0.05
Others
Malignancies
0.09
0.13
0.11
Table 11. Size of fibers in lung parenchyma:
than 8 pm (%). proportion of fibers longer
Pathological Fiber concentration in the 1ung, Nb cm 3
features
Asbestosis t <106 106 - 107 >107 Average
Respiratory
Cancer 11.6 20.1 20.8 18.6
Mesothelioma 13.1 20.5 11.4 15
Lung Cancer
Others 0.7 0.7
Malignancies 1.6 6.3 4.1
107

2. Asbestos Fiber Parameters A~_ccordin to ~Samp~lin_q Sites in Respiratory Tissues:
ar~ enhymaar et~TP leura, ~iastinaT Lymp~i Nes.
Besides lung parenchyma samples parietal pleura samples were available in 13 cases
and mediastinal lymph node.samples in 4 of these cases.
The comparison of fiber concentration in lung parenchyma and parietal pleura is
indicated on figure 4. The absenceoF-correlation between asbestos fiber content in
parenchymal and pleural tissue is emphasized. It is noteworthy that in some mesothelioma
cases, even with high concentration inside lung parenchyma, the fiber concentration in the
parietal pleura was very low. By contrast, a correlation seemed to appear between the
fiber concentration in parietal pleura and in lymph nodes (figure 5).
107
108
10 106 10 f
LUNG PARENCHYMA
M
A
AM M
M
A
A
105
104
M
M M M M
FIBERS IN LUNG AND
PLEURA (Nb.cw3)
M. Masetheliom.
A. Asbsstesis ± Luny
Cancer
Figure 4. Correlation between asbestos fiber concentration in lung and in parietal
pleura (see text for comments).
108

CS
A
A
y
W
PARIETAL PLEURA
105 106 10 7
A I I I
FIBERS IN PLEURA AND
LYMPH NODES (Nb.cm3)
Figure 5. Correlation between asbestos fiber concentration in parietal pleura and
mediastinal lymph nodes.
The comparison of mineralogical types has been carried out in the same way. The most
striking features were:
a) Most of TEM fibers encountered in parietal pleura were of chrysotile type even
when the proportion of amphibole/amphibole + chrysotile type fibers was higher than 0.5 in
the lung parenchyma (figure 6).
b) By contrast, so far in the few cases studied, most of the fibers encountered in
lymph nodes were of amphibole type (figure 6).
The fiber size has been compared in the different sampling sites (Table 12). The
longest ftT ers were found in the lung and the thinnest in the parietal pleura. Mean fiber
length was of 4.9 pm for lung parenchyma, 2.3 pm for parietal pleura, and 2.5 pm for lymph
nodes.
N
~
109 W
f+
~
~
00

COS
Ratio (AmPhiielas/Amp hib olms + ChrYsotilo) x 100
100
E-50
A
50 1g0
1~ _ AA A
LUNG PARENCHYMA
100
Dp
0
F-5
50 100
PARIETAL
PLEURA
LYMPH
NODES
Figure 6. Ratio of amphiboles count/total asbestos fibers count in lung parenchyma coopared
to the ratio in parietal pleura (top) and to the ratio in lyvph nodes (bottom).
110

CS
Table 12. Fiber size in lung parenchyma, parietal pleura,
and lymph nodes.
Lung
parenchyma Parietal
pleura Lymph
nodes
Mean Length
um 4.9 2.3 2.5
Mean Diameter
um
Proportion of Fibers 0.13 0.06 0.16
Longer than 8 um
percent 15 2 3
Discussion
{
The contribution of this metrologic study of asbestos dusts in the human PT is
relevant to three major points relating to the pathophysiology of fibrous particles:
- It allowed a check of the reliability of monitoring asbestos in sputum and lung
washing fluid for the assessment of asbestos exposure.
- It provided a better understanding of the partition of fibers in the different
compartments of the respiratory system, which allows hypothesis about the translocation of
fibers in the PT.
- It yielded quantitative data concerning the actual fiber dimensions in humans in
different diseases, including pleural mesotheliomata, which have to be discussed in view
of recent experiments concerning the mesothelial response in relation to fiber dimension.
A. External Indicators of Asbestos Lung Burden.
The present work demonstrated that the study of sputum and LWF by LM and TEM was very
reliable for the assessment of asbestos exposure in heavily exposed people. The advantage
of LWF over sputum is that it yields a greater amount of fibers which are most
representative of the alveolarly deposited fraction. This technique, which requires that
the patient accept a fiberoptic bronchoscopy, might help to diagnose asbestos-related
diseases. However, this possibility has some limitation. Indeed, the information
provided by BAL carried out in moderately exposed people was much less reliable than the
study of lung parenchyma. This can be easily understood since we will discuss later on
that the percentage of intraalveolar fibers is very low compared to the fibers retained in
lung parenchyma.
However, it seems that LM and TEM study of sputum is an excellent tool for detecting
and following exposed people [9,11]. A cytological control of the sputum looking for, AM
is needed to be sure that it represents the mineral content of the deep lung. It is
possible that the measurement of asbestos fibers in other biological samples could be
better indicators of asbestos body-burden, as discussed elsewhere [50]. Thus the search
for asbestos fibers in feces appeared to be a very sensitive method, allowing detection of
low intake of asbestos fibers [12].
B. Translocation of Asbestos Fibers in the Respiratory System.
The figure 7 summarizes all the mean data concerning number, length, and diameter of
fibers in four sites of the respiratory system: alveoli, LP, PP and LN. Moreover, the
figure 8 gives the distribution of length fibers in these four sites.
111
2063104910

Figure 7. Diagram comparing the mean number (Nb), mean length (L) and mean diameter
(d) of asbestos fibers in 4 sites of the respiratory system. Numbers have
been estimated for the whole lung for parenchyma (Par) and alveoli (Alv),
while they are given per cc of tissue for pleura and lymph nodes (LN).
112

percent
30
20
t0
30
20
10
30
20
10
30
20
10
LUNG PARENCHYMA
1 2 4 6 8 16 32 µm
PARIETAL PLEURA
LYMPH NODES
ALVEOLUS
Figure 8. Distribution of fibers length in parenchyma, parietal pleura, lymph nodes
and alveoli. Note that long fibers, more than 4{rm in length, are less
frequent in pleura, lymph nodes and alveoli than in parenchyma.
113
1

,--
For LP and alveoli, the fiber counts have been integrated for the whole lung,
distinguishing intra-alveolar fibers assessed by the BAL and intra-parenchymal fibers
assessed by destroying LP. Thus, the fraction corresponding to LP totalizes fibers
entrapped in the pulmonary interstitial tissue (plus fibers inside blood vessels?) and
fibers within the alveolar compartment. For that estimation, the volume of total lung has
been assumed to be 5000 mL and the fraction of alveolar spaces washed by the BAL to be
1/20 of the whole lung volume. Thus, the figure 7 shows that the intra-alveolar fraction
of all intra-parenchymal fibers would only represent about 1 percent of all the fibers
retained in lung tissue, when assumed that BAL recovered all intra-alveolarly deposited
fibers.
The mineralogical type of alveolar and interstitial asbestos dusts did not differ
significantly, as indicated on one hand by the electron diffraction pattern and on the
other hand by the measurement of fiber diameters, identical in both sites (0.13 pm in mean
diameter).
Elsewhere, it is noteworthy that the intra-alveolar fibers were significantly shorter
(3.3 pm in mean length) than the interstitial fibers (4.9 pm in mean length for LP
fibers). This difference must even be more important, because the mean length of
interstitial fibers is probably reduced by adding the 1 percent of short alveolar fibers
to the interstitial fibers when LP is studied; on the other hand, it is possible that the
mean length of intra-alveolar fibers is increased by the addition of longer fibers
deposited at the surface of the peripheral airways and washed out during the BAL. Indeed,
the mean length of fibers in sputum was found to be 5 pm (Table 5). These results clearly
indicate a shorter length of fibers inside alveoli compared to pulmonary interstitial
tissue. This can be related to two mechanisms, more or less associated (figure 9); either
long fibers might penetrate more easily across the alveolar membrane or small fibers are
more easily cleared from the interstitial tissue toward the alveolar spaces? As will be
discussed, sizing of fibers in pleura and in lymph nodes brings a clue in the favor of the
last hypothesis.
Indeed, in these two sides (PP and LN), the asbestos fibers were significantly
shorter than in lung parenchyma (2.3 pm in PP; 2.5 pm in LN compared to 4.9 pm in LP).
These findings are additional clues to the greatest translocation effectiveness of short
fibers. The migration of fibers was found even more selective in this study, since mostly
chrysotile fibers were found inside the PP, with a mean diameter of 0.06 pm, whereas
mostly amphibole type fibers with a mean diameter of 0.16 pm were found in mediatinal LN.
This selective migration of fibers might be mostly related to their dimension, as if only
short and very thin fibers could be entrapped in the PP tissue (figure 9).
C. Fibers Dimension Related to Carcinogenicity.
The aforementioned recent animal experiments after implantation of fibers in the
pleura [3,5] reinforced the idea that the carcinogenicity of fibers depends only on
dimension of fibers, whatever the chemical composition is, in such a way that the
probability to induce pleural cancer reaches 100 percent when all the fibers are less than
0.25 Nm in diameter and more than 8 Nm in length (see Stanton et al. , this meeting).
In humans, as demonstrated by this work and by others [24,26,57], all the asbestos
fibers encountered in different sites of the respiratory system were found to have a
diameter less than 0.25 pt. By contrast, the present study has clearly demonstrated that
the mean length of fibers was always less than 8 pm in all sites (figure 7). However, a
certain percentage of fibers was longer than 8 pm, especially in lung parenchyma (15
percent) (see Table 12 and figure 8). The point is to understand how such few fibers,
distant from the parietal pleura, might induce the carcinogenetic transformation of
mesothelial cells, or if other mechanisms specific to humans are to be considered.
114

PLEURA
LP
t
// ~ ~
A>C` lzt
Alv.
Figure 9. Diagram showing the hypothetic different selective translocation pathways
of fibers in the respiratory system. The longest fibers are retained
within the lung parenchyma (LP) with more amphibole-type fibers than
chrysotile-type fibers (A > C). The shortest fibers migrate either towards
the parietal pleura (Par P1) and mostly of chrysotile-type (C), or towards
the lymph nodes (LN) and mostly of amphibole-type (A). The fibers are
shorter within the alveoli (Alv) than in lung parenchyma (LP); this must be
due to the selective translocation of short fibers from the pulmonary
interstitial tissue (1).
The microprobe analyses have been carried out in the Laboratoire de Biophysique
Medicale (Pr P. Galle) in collaboration with J. P. Berry.
Part of this work has been supported by the Minist4re de la Qualite de la Vie and by
the Institut National de la Sant4 et de 1a Recherche Mdicale.
N
4
115 ~
~
~
r
~

0%
References
[1] IARC Monographs on the evaluation of carcinogenic risk of chemical to man, Asbestos,
14, WHO, IARC Publications (1977).
[2] Zielhuis, R. L., Public Health risks of exposure to asbestos, European Economic
Community, Directorate of Socials Affairs, Health and Safety Directorate, Pergamon
Press (1977).
[3] Stanton, M. F., Layard, M., Tegeris, A., Miller, E., May, M., and Kent, E.,
Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber
dimension, J. Natl. Cancer Inst. 58, 587-603 (1977).
[4] Pott, F., Friedrichs, K. H., and Huth, F., Ergebnisse aus Tierversuchen zur
kanzerogenen Wirkung faserfgrmiger StaUbe und ihre Deutung im Hinblick auf die
Tumorentstehung being Menschen, Zbl. Bakt. ~Zq. I Abt. Ori . B. 162, 467-505 (1976).
[5] Meeting on the biological relevance of fiber parameters, IARC June 30-July 1, Lyon
(1977).
[6] Task group on lung dynamics, Deposition and retention models for internal dosimetry
of the human respiratory tract, Health Phys. 12, 173-207 (1966).
[7] Pontefract, R. 0. and Cunningham, H. J., Penetration of asbestos through the
digestive tracts of rats, Nature, 243, 352-353 (1973).
[8] Cohen, 0., Ferromagnetic contamination in the lungs and other organs of the human
body, Science, 180, 745-748 (1973).
[9] Bignon, J., Depierre, A., Bonnaud, G., Goni, J., and Brouet, G., Mise en evidence des
corps ferrugineux par microfiltration de 1'expectoration, Nouv. Presse Med. 2, 1697-
1700 (1973).
[10] Sluis-Cremer, G. K., Asbestosis in South Africa. Certain geographical and
environmental considerations, Ann. N.Y. Acad. Sci. 132, 215-234 (1965).
[i1] Bignon, J., Sebastien, P., Jaurand, M. C., and Hem, B., Microfiltration method for
quantitative study of fibrous particles in biological specimens, Environ. Health
Persp. 9, 155-160 (1974).
[12] Cunningham, H. M., Pontefract, R. D., and O'Brien, R. C., Quantitative relationship
of fecal asbestos to asbestos exposure, J. Toxicol. Environ. Health, 1, 377-379
(1976).
[13] Timbrell, V., The inhalation of fibrous dusts, Ann. N.Y. Acad. Sci. 132, 255-273
(1965).
[14] Harris, R. L. and Fraser, 0. A., A model for deposition of fibers in the human
respiratory system, Aat. Industr. Hyg. Assoc. J. 3, 73-89 (1976).
[15] Mossman, B. T., Kessler, J. B., Ley, B. W., and Craighead, J. E., Interaction of
crocidolite asbestos with hamster respiratory mucosa in organ culture, Lab. Invest.
36, 131-139 (1977).
[16] Wagner, J. C., Berry, G., Skidmore, J. W., and Timbrell, V., The effect of the
inhalation of asbestos in rats, Br. J. Cancer 29, 252-269 (1974).
[17] Morgan, A., Evans, J. C., Evans, R. J. , Hounam, R. F., Holmes, A., and Doyle, S. G.,
Studies on the deposition of inhaled fibrous material in the respiratory tract of the
rat and its subsequent clearance using radioactive tracer techniques II. Deposition
of the UICC standard reference samples of asbestos, Environ. Res. 10, 196-207 (1975).
116
S

[18] Evans, J. C., Evans, R. J., Holmes, A., Hounam, R. F., Jones, D. M., Morgan, A. and
Walsh, M., Studies on the deposition of inhaled fibrous material in the respiratory
tract of the rat and its subsequent clearance using radioactive tracer techniques,
Environ. Res. 6, 180-201 (1973).
[19] Stumphuis, J., Epidemiology of mesothelioma on Walcheren Island, Br. J. Industr. Med.
28, 59-66 (1971).
[20] Bignon, J., Sebastien, P., Monchaux, G. and Bonnaud, G., L'Epuration ii long terme des
particules fibreuses chez 1'homme, Collogues de 1'INSERM, 29, 205-218 (1974).
[21] Langer, A. M., Selikoff, I. J., and Sastre, A., Chrysotile asbestos in the lungs of
persons in New York City, Arch. Environ. Health 22, 348-360'(1971).
[22] Pooley, F. D., Electron microscope characteristics of inhaled chrysotile asbestos
fiber, Br. J. Industr. Med. 29, 146-153 (1972).
[23] Pooley, F. D., Methods for assessing asbestos fibers and asbestos bodies in tissue by
electron microscopy. In Biological effects of asbestos, Proceedings of a Working
Conference held at the IARC, Lyon, France, 2-6 October 1972. IARC Scientific
Publications n° 8, pp. 50-53 (1973).
[24] Fondimare, A. and Desbordes, J., Asbestos bodies and fibers in lung tissues__ _
Environ. Health Persp. 9, 147-148 (1974).
[25] Sebastien, P., Fondimare, A., Bignon, J., Monchaux, G. , Desbordes, J., and Bonnaud,
G. , Topographic distribution of asbestos fibers in human lung in relatian with
occupational and non-occupational exposure. Fourth International Symposium on
Inhaled Particles and Vapours of the BOHS, Edinburgh (22-26 September 1975).
[26] Le Bouffant, L., Bruyere, S., Martin, J. C., Tichoux, G., and Normand, C., Quelques
observations sur les fibres d'amiante et les formations minerales diverses
rencontr4es dans les poumons asbestosiques, Rev. Fr. Mal. R2sp. 4, su 1. 2, 121-140
(1976).
[27] Gross, P., Harley, R. A., Davis, J. M. G., and Cralley, L. J., Mineral fiber content
of human lungs, Am. Industr. ~Xq. Assoc. J. 35, 148- (1974).
[28] Gross, P., Davis, J. M. G. , Harley, R. A., and de Treville, R. T. P., Lymphatic
transport of fibrous dust from the lungs, J. Occup. Med. 15, 186-189 (1973).
[29] Pooley, F. D., Personal communication (1976).
[30] Bignon, J. and Sebastien, P., Unpublished data.
[31] Hourihane, 0. 0. B., A biopsy series of mesothelioma and attempts to identify
asbestos within some of the tumors, Ann. N.Y. Acad. Sci. 132, 647-673 (1965).
[32] Henderson, W. J., Evans, D. M. D., Davies, J. D., and Griffiths, K., Analysis of
particles in stomach tumors from Japanese males, Environ. Res. 9, 240-249 (1975).
[33] Chatel, A., Mignon, F., Sebastien, P., Hirsch, A., Bignon, J., Bader, J. P., and
Chretien, J., Exploration. oeso-gastrique avec recherche de fibres d'amiante d'une
s6rie de malades exposes is 1'amiante, Arch. Mal. 8pp. Dii. (in press).
[34] Pooley, F. D., Locating fibers in the bowel wall, Environ. Health Persp. 9, 235
(1974).
[35] Rosen, P., Savino, A., and Melamed, M., Ferruginous (asbestos) bodies and primary
carcinoma of the colon, A.J.C.P. 61, 135-138 (1974).
rsp. 9,
(36] 241u252 (1974)nteraction of asbestos with alveolar cells, Environ. Health Persp.
117
2063104916

[37] Roe, F. J. C., Carter, R. L., Walters, M. A., and Harington, J. 5., The pathological
effects of subcutaneous injections of asbestos fibers in mice: migration of fibers
to submesothelial tissues and induction of inesotheliomata, Int. J. Cancer 2, 628-638
(1967).
[38] Karacharova, V. N., Olshvang, R. A., and Kooan, F. M., On changes of certain organs
after intraperitoneal administration of asbestos containing dust in experiment,
Byull. EksQ. Biol. Med. 67, 117-120 (1967).
[39] Morgan, A., Holmes, A., and Gold, C., Studies of the solubility of constituents of
chrysotile asbestos in vivo using radioactive tracer techniques, Environ. Res. 4,
558-570 (1971).
[40] Friedrichs, K. H., Hilscher, W. , and Sethi, 5., Staub und gewebe untersuchungen an
rattennach intraperitonealer injektion von asbest, Int. Arch. Arbeits. Med. 28, 341-
354 (1971).
[41] Cunningham, H. M. and Pontrefact, R. 0., Asbestos fibers in beverages, drinking
water, and tissues: their passage through the intestinal wall and movement through
the body, J. AOAC J6, 976-981 (1973).
[42] Gross, P., Harley, R. A., Swinburne, L. M., Davis, J. M. G., and Green, W. B.,
Ingested mineral fibers, Arch. Environ. Health 29, 341-347 (1974).
[43] Bignon, J. , Masse, R., and Sebastien, P. , Unpublished data.
[44] Berry, J. P., Henoc, P., Galle, P., and Pariente, R. , L'empoussierage pulmonaire:
etude par microscopie electronique, microanalyse par sonde ectronique,
microdiffraction d'6lectrans, J. Microscopie 17, 11-18 (1975).
[45] Pooley, F. 0. and Sebastien, P., Asbestos fibers from mesothelioma cases, Results of
an intercomparison program (1976).
[46] Reynolds, H. Y. and Newball, H. H., Analysis of proteins and respiratory cells
obtained from humans lung by bronchial lavage, J. Lab. Clin. Med. 84, 559-573 (1974).
[47] Daniele, R. P., Altose, M. 0., and Rowlands, 0. T., Immunocompetent cells from the
lower respiratory tract of normal human lungs, J. Clin. Invest. 56, 986-995 (1975).
[48] Nolibe, D., Metivier, H., Masse, R., and Lafuma, J., Therapeutic effects of pulmonary
lavage, in vivo, after inhalation of insoluble radioactive particles, Fourth
International Symposium on Inhaled and Vapours of the BOHS, Edinburgh, 22-26
September 1975 (in press).
[49] Basset, F. , Soler, P., Jaurand, J. C., and Bignon, J. , Ultrastructural examination of
broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X, Thorax 32, 303-
306 (1977).
[50] Bignon, J. , Sebastien, P., and Bientz, M., Review of some factors relevant to the
assessment of exposure to asbestos dusts, International workshop on biological
specimen collection, Luxembourg 18-22 April 1977 (in press).
[51] Pooley, F. 0. , Oral communication, Meeting on the biological relevance of fiber
parameters, IARC June 30-July 1, Lyon (1977).
118

Discussion
~: FISHER: I noticed you used the term amphibole in your tables. Since I believe
these were insulation workers, you mean amosite rather than the general mineral group?
J. BIGNON: The identification of asbestos fibers has been done only by the morphology
in TEM and by electron diffraction. As we did not use microanalysis to identify the
different type of amphibole, and as we did not get accurate inquiries about the material
used by patients, I cannot answer your question.
FISHER: But these were insulation workers, am I correct?
BIGNON: Yes. These workers sprayed a mixture of asbestos and other material; but as
the material used by these workers changes from time to time, it is difficult to identify
by a questionnaire the type of asbestos fibers to which the patients have been exposed.
FISHER: The type of amphibole used would be one that would be considered a commercial
form of asbestos and would only be useful for that purpose if it did have the long fiber
length that you showed in your tables. I am trying to distinguish between this type of
amphibole and the more general, more widely occurring forms. I think that's an important
point.
M. SCHNEIDERMAN: Is your question related to the fact that the type of amphibole
used by the insulation workers is in some manner different from what one has in some other
kinds of general exposures; is that what you're driving at?
FISHER: Exactly, yes.
SCHNEIDERMAN: Yes, I think Prof. Bignon agrees with you.
G. WRIGHT: I have one question which is becoming increasingly bothersome. In looking
at old materials from autopsies, the question of whether or not the material that was used
for fixing the lung contains asbestos fiber is beginning to be raised. I would ask whether
the materials you used in fixing the lung had been demonstrated to be asbestos fiber-free?
The other is a comment, because your study, I think, demonstrates rather well the fol-
lowing: the lung apparently is a concentrator of long fibers. In most occupational
exposures, the ratio of fibers longer than 5 pm to those that are shorter is of the order
of 20 to as much as 50 or 100 to 1. So if you find 17 percent of the residual fibers in
the parenchyma are longer than 8 pm, this strongly suggests that the lung preferentially
concentrates the, long fibers. There is very recent evidence by Arthur Morgan, in experi-
mental animals, of precisely what you've shown. In acute experiments lasting for several
months, the animal rather rapidly clears the short fibers and retains the long ones. So
it's a very nice confirmation of your observations.
BIGNON: The liquids we have used for lung fixation and processing were constantly
filtered through 0.5 pm Millipore filters.
N
~
119 W
H+
~
,.+
~
